Home/ Supplements/ Electrolytes/ Plasminogen Activator

Plasminogen Activator

product on market Capsule SuperSmart Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile contains nattokinase and serrapeptase, which have moderate evidence for supporting fibrinolytic activity. Grape seed extract and pterostilbene provide antioxidant properties, while magnesium ascorbyl phosphate serves as a stable vitamin C derivative. Overall, research on these combined ingredients for plasminogen activation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Plasminogen Activator
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Within RDA (0.7× RDA) 316 studies (A:8, B:159)
200 mg
Market median: 100.0mg (70 products)
Serrapeptase
200 mg
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
Market median: 167.0mg (311 products) 183 studies (A:0, B:65)
75 IU (416% DV)
3.4× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)

Other Ingredients

Acacia Gum White Rice Flour
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended use: Adults. Take two capsules a day.

Warnings & Precautions

Precautions: Do not exceed the recommended daily dose. This product is a nutritional supplement and should not replace a varied, balanced diet.

Keep out of childrens' reach.

As with any nutritional supplement, you should consult a health professional before taking this product if you are pregnant, breastfeeding or have a health problem.

Formulation Notes

Premium Formulation

Additional Information

Store away from direct light, heat and humidity.

Vitamin C: 175%

Metadata

Product Details

UPC / SKU5 453003 828082
DSLD Entry Date2025-06-25
Product TypeOther Combinations
FormCapsule
DSLD ID332481
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.